PHARMACY

Lupin’s generic Onfi gets FDA approval

BY Sandra Levy

Lupin has received the Food and Drug Administration’s blessing for Clobazam oral suspension, 2.5 mg/mL.

The product is a generic version of Lundbeck’s Onfi oral suspension, 2.5 mg/mL.

It is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in patients 2 years of age or older.

Clobazam oral suspension, 2.5 mg/mL had a market value of approximately $260.2 million, according to IQVIA September 2018 data.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

New York City pharmacies banned from selling cigarettes

BY Sandra Levy

New York City pharmacies are prohibited from selling cigarettes and other tobacco products, thanks to a bill which went into effect on Jan. 1.

The bill, which was signed by Mayor Bill de Blasio in 2017, also prohibits pharmacies from selling e-cigarettes and was part of a package of anti-smoking bills that also raised the minimum price of cigarettes to $13 a pack.

“People trust pharmacies to help them stay well — they should be helping smokers quit, not the opposite,” Deputy Mayor for Health and Human Services Herminia Palacio said in a statement.

Many pharmacies have voluntarily stopped selling tobacco products, including CVS Health, which discontinued selling cigarettes in 2014.

About 500 pharmacies still sell tobacco products, according to the city.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
Innovation PharmASSIST
PHARMACY

HealthWarehouse.com implements Innovation’s PharmASSIST

BY Sandra Levy

Florence, Ky-based HealthWarehouse.com is touting dramatic improvements in its operational efficiency just six months after replacing prior automation with Innovation’s PharmASSIST high-volume Quick Start prescription fulfillment system.

“We’ve reinvented our prescription production by moving to a fully automated and scalable set of advanced technologies that has enabled us to add volume and increase our overall throughput without adding staff,” HealthWarehouse.com president and CEO, Joseph Peters said. “By eliminating high-touch manual processes, our filling accuracy rates are the highest we’ve ever experienced and we’ve reduced our cost to fill prescriptions by over 10%, enabling us to continually increase our EBITDA.”

Innovation’s PharmASSIST RDS robotic dispensing technology, which is fully outfitted with Model 4 dispensers, highlights HealthWarehouse.com’s custom Quick Start system. The dispensers all count simultaneously and self-calibrate the dispensing of new medications. PharmASSIST Symphony for High Volume drives the entire high-volume workflow and production from order intake through filling, packaging, and shipping.

“As important as our improved production, we’ve paid special attention to our customer service and patient services. We’ve reallocated various resources from our production environment to address more patient-centered tasks including counseling, acquisition and retention, and adherence. And, we’re doing all of this while reducing our operational hours from a 12-hour to a 9-hour day,” Peters said.

Healthwarehouse.com purchased their PharmASSIST High Volume Solution in the fall of 2017.

“Healthwarehouse.com is a true success story. They have a vision and are committed to achieving it. We’re pleased to be their strategic business partner and help them move forward with realizing their goals,” Innovation’s divisional vice president of sales, chain and high volume, Steve Donohue said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?